產(chǎn)品詳情
簡單介紹：
Anti-CYLD抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-CYLD抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-CYLD
Cat. Number:
Anti-CYLD抗體KL-2756R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Defects in CYLD are the Anti-CYLD抗體cause of familial cylindromatosis (CYLD) also known as turban tumor syndrome or dermal eccrine cylindromatosis. CYLD is an autosomal dominant and highly tumor type-specific disorder. The tumors (known as cylindromas because of their characteristic microscopic architecture) are believed to arise from or recapitulate the appearance of the eccrine or apocrine cells of the skin that secrete sweat and scent respectively. Cylindromas arise predominantly in hairy parts of the body with approximately 90% on the head and neck. The development of a confluent mass which may ulcerate or become infected has led to the designation "turban tumor syndrome". The skin tumors show differentiation in the direction of hair structures, hence the synonym trichoepithelioma. CYLD has deubiquitinating activity.
Also known as:
CDMT; cylindromatosisAnti-CYLD抗體 (turban tumor syndrome); cylindromatosis 1; Deubiquitinating enzyme CYLD; EAC; HSPC057; KIAA0849; turban tumor syndrome; Ubiquitin thiolesterase CYLD; Ubiquitin-specific processing protease CYLD; CYLD_HUMAN; Ubiquitin carboxyl-terminal hydrolase CYLD; CYLD; BRSS; CDMT; CYLD1; CYLDI; EAC; MFT; MFT1; SBS; TEM; USPL2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human cylindromatosis 1.
●
Predicted Molecular Anti-CYLD抗體Weight: 105kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-CYLD抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-CYLD抗體 must be determined by the end user.
kl066Mu02 白介素1受體Ⅰ(IL1R1)多克隆抗體 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1)
kl068Mu02 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)多克隆抗體 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
kl071Mu02 白介素1α(IL1α)多克隆抗體 Polyclonal Antibody to Interleukin 1 Alpha (IL1a)
kl072Bo01 防御素β2(DEFβ2)多克隆抗體 Polyclonal Antibody to Defensin Beta 2 (DEFb2)
kl072Mu02 防御素β2(DEFβ2)多克隆抗體 Polyclonal Antibody to Defensin Beta 2 (DEFb2)
kl073Mu02 白介素2(IL2)多克隆抗體 Polyclonal Antibody to Interleukin 2 (IL2)
kl074Mu02 **球蛋白G1(IgG1)多克隆抗體 Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl074Ra01 **球蛋白G1(IgG1)多克隆抗體 Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl076Mu02 白介素3(IL3)多克隆抗體 Polyclonal Antibody to Interleukin 3 (IL3)
kl077Gu01 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Mu02 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Ov01 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Si01 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl078Mu02 白介素5(IL5)多克隆抗體 Polyclonal Antibody to Interleukin 5 (IL5)
kl079Mu02 白介素6(IL6)多克隆抗體 Polyclonal Antibody to Interleukin 6 (IL6)
kl081Mu02 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl083Mu02 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl084Mu02 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl086Mu02 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl087Mi02 單核細胞趨化蛋白1(MCP1)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 1 (MCP1)
kl089Mu02 單核細胞趨化蛋白3(MCP3)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3)
